Article
Version 1
Preserved in Portico This version is not peer-reviewed
Direct Use of Clinical Tolerance Limits for Assessing Agreement: A Robust Nonparametric Approach
Version 1
: Received: 15 August 2021 / Approved: 16 August 2021 / Online: 16 August 2021 (13:53:22 CEST)
How to cite: Indrayan, A. Direct Use of Clinical Tolerance Limits for Assessing Agreement: A Robust Nonparametric Approach. Preprints 2021, 2021080343. https://doi.org/10.20944/preprints202108.0343.v1 Indrayan, A. Direct Use of Clinical Tolerance Limits for Assessing Agreement: A Robust Nonparametric Approach. Preprints 2021, 2021080343. https://doi.org/10.20944/preprints202108.0343.v1
Abstract
Clinical agreement between two quantitative measurements on a group of subjects is generally assessed with the help of the Bland-Altman (B-A) limits. The interpretation regarding agreement is based on whether B-A limits are within the pre-specified clinical tolerance. Thus, clinical tolerance limits are necessary for this method. We argue in this communication that such limits of clinical tolerance can be directly used for assessing agreement and plead that this nonparametric approach is simple and robust to the distribution pattern and outliers. Such direct use of clinical tolerance limits has more flexibility, and it is more effective in assessing the extent of agreement.
Keywords
Agreement analysis; Bland-Altman method; Clinical tolerance limits; Limits of agreement; Nonparametric approach; Robust method
Subject
Medicine and Pharmacology, Clinical Medicine
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment